Ebb Therapeutics
Ebb Therapeutics develops regional cerebral thermal therapy (RCTT) device for use in insomnia and sleep disorders.
Funding reportedLast round: Series B
What company datasets say Ebb Therapeutics raised
Funding, as reported
Reported in all38Min the source's currency
Rounds1
Last roundSeries B
Last round dateJan 2017
Investors listed4
On a portfolio page
Investors who name them
Each firm lists Ebb Therapeutics on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Genetics in the same market
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Ebb Therapeutics in front of investors. Or tell us what we have wrong.